Defining the factors that contribute to on-target specificity of antisense oligonucleotides.

by Walt F Lima, Timothy A Vickers, Josh Nichols, Cheryl Li, Stanley T Crooke
Published 2014-01-01

The diathermy scratch pad: A cheap and efficient tool for chemical and explosion-related burns

by Allen Wei-Jiat Wong, Qi En Hong, Cheryl Li Yu Hui, Si Jack Chong
Published 2019-01-01

Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascend...

by Spencer I. Danto, Negin Shojaee, Ravi Shankar P. Singh, Cheryl Li, Steven A. Gilbert, Zorayr Manukyan, Iain Kilty
Published 2019-12-01

Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii...

by Cheryl Li Ling Lim, Alvin Qijia Chua, Jocelyn Qi Min Teo, Yiying Cai, Winnie Lee, Andrea Lay-Hoon Kwa
Published 2018-11-01

Early Renal Replacement Therapy and Total Body Wrap Topical Negative Pressure Wound Therapy for Severe Burns and Rhabdomyolysis: A Case Report

by Yee Onn Kok MBBS, MRCS, Cheryl Li Yu Hui MBBS, Si Jack Chong MRCS, FAMS, Bien Keem Tan FRCS, FAMS
Published 2014-12-01

357 TAK-573, an anti-CD38–attenuated interferon alpha (IFNα) fusion protein (Attenukine™), has demonstrated IFNα receptor (IFNAR) pathway modulation in patients with relapsed/refra...

by Cheryl Li, Lei Shen, Sabrina Collins, Adarsh Joshi, Subhasree Das, Kaveri Suryanarayan, Dean Bottino, Michael Curley, Dannie Wang, Michael Abadier, Ryan Larson, Xavier Parot
Published 2020-11-01